Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with a type of breast cancer that is hormone receptor-positive (HR+), confirmed by laboratory testing.
- People who are 18 years of age or older.
- People who have been taking a type of hormone-blocking medication called an aromatase inhibitor (such as anastrozole, letrozole, or exemestane) for at least 2 months.
- People who are experiencing joint pain or muscle discomfort linked to their aromatase inhibitor medication, with a worst joint pain score of at least 2 out of 10 on a standard pain questionnaire over the past 7 days.
- People who are able to understand what the study involves and are willing to sign a consent form agreeing to take part.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have had a bone fracture or major surgery in the past 6 months.
- People who have been diagnosed with arthritis, such as rheumatoid arthritis.
- People who have been diagnosed with osteoporosis based on standard medical measurements (a bone density T-score of -2.5 or lower).
- People whose breast cancer has come back or spread to other parts of the body, or who are receiving chemotherapy or radiotherapy during the study period.
- People who have been diagnosed with another type of cancer.
- People who have serious problems affecting the heart, brain, liver, or kidneys, or who have an active infectious disease.
- People who have severe mental health, cognitive, or behavioural conditions that would make it difficult to understand or participate in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +251913105648
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Musculoskeletal Pain Severity and Pain Interference
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.